AstraZeneca
AZN
AZN
544 hedge funds and large institutions have $17.3B invested in AstraZeneca in 2018 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 151 increasing their positions, 197 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
544
Holders Change
+14
Holders Change %
+2.64%
% of All Funds
12.46%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
65
Increased
151
Reduced
197
Closed
47
Calls
$225M
Puts
$73.5M
Net Calls
+$152M
Net Calls Change
+$45M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$810M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$597M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$164M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$106M |
| 5 |
Primecap Management
Pasadena,
California
|
+$93.5M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$129M |
| 2 |
SCCM
Schafer Cullen Capital Management
New York
|
-$106M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$80.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$68.7M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$64.7M |
